BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36434748)

  • 1. Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis.
    Panunzio A; Barletta F; Tappero S; Cano Garcia C; Piccinelli M; Incesu RB; Law KW; Tian Z; Tafuri A; Tilki D; De Cobelli O; Chun FKH; Terrone C; Briganti A; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
    J Surg Oncol; 2023 Mar; 127(4):560-567. PubMed ID: 36434748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinoma.
    Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Siech C; Goyal JA; Touma N; Tian Z; Saad F; Shariat SF; Creta M; Califano G; Celentano G; Colla' Ruvolo C; Ahyai S; Carmignani L; de Cobelli O; Musi G; Briganti A; Chun FKH; Longo N; Karakiewicz PI
    J Surg Oncol; 2024 Apr; ():. PubMed ID: 38606531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis.
    Tran TB; Liou D; Menon VG; Nissen NN
    Am Surg; 2013 Oct; 79(10):1115-8. PubMed ID: 24160811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol.
    Rodriguez-Galindo C; Krailo MD; Pinto EM; Pashankar F; Weldon CB; Huang L; Caran EM; Hicks J; McCarville MB; Malkin D; Wasserman JD; de Oliveira Filho AG; LaQuaglia MP; Ward DA; Zambetti G; Mastellaro MJ; Pappo AS; Ribeiro RC
    J Clin Oncol; 2021 Aug; 39(22):2463-2473. PubMed ID: 33822640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
    Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
    Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
    Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
    World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry.
    Xiao WJ; Zhu Y; Dai B; Zhang HL; Shi GH; Shen YJ; Zhu YP; Ye DW
    Oncotarget; 2015 Dec; 6(42):44955-62. PubMed ID: 26510907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management and clinical prognosis of adrenocortical carcinoma.
    Dong D; Li H; Yan W; Ji Z; Mao Q
    Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
    Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
    Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional survival of stage III non-seminoma testis cancer patients.
    Incesu RB; Barletta F; Tappero S; Morra S; Garcia CC; Scheipner L; Piccinelli ML; Tian Z; Saad F; Shariat SF; de Cobelli O; Ahyai S; Chun FKH; Longo N; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
    Urol Oncol; 2023 Oct; 41(10):435.e11-435.e18. PubMed ID: 37558516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?
    Kebebew E; Reiff E; Duh QY; Clark OH; McMillan A
    World J Surg; 2006 May; 30(5):872-8. PubMed ID: 16680602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of adrenocortical tumors in children.
    Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
    J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.
    Poorman CE; Ethun CG; Postlewait LM; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solórzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    Ann Surg Oncol; 2018 Feb; 25(2):520-527. PubMed ID: 29164414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
    Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
    Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
    Wu K; Liu Z; Li X; Lu Y
    Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality.
    Mistretta FA; Palumbo C; Knipper S; Mazzone E; Pecoraro A; Tian Z; Musi G; Perrotte P; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
    World J Urol; 2020 Mar; 38(3):725-732. PubMed ID: 31297629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcome of stage III and IV adrenocortical carcinoma.
    Ohwada S; Izumi M; Kawate S; Hamada K; Toya H; Togo N; Horiguchi J; Koibuchi Y; Takahashi T; Yamada M
    Jpn J Clin Oncol; 2007 Feb; 37(2):108-13. PubMed ID: 17277000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
    Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
    J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hispanic
    Panunzio A; Tappero S; Garcia CC; Piccinelli M; Barletta F; Incesu RB; Tian Z; Tafuri A; Tilki D; Briganti A; DE Cobelli O; Chun FKH; Terrone C; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
    Anticancer Res; 2022 Nov; 42(11):5579-5585. PubMed ID: 36288855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.